date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.427226481044656.
The log-likelihood improved by 3.065.
Iteration 2 of at most 500:
Optimizing with step length 0.777331633111967.
The log-likelihood improved by 3.209.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.4938.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.4098.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       7       18     1169     1015      772      377      378      373 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     304      207      181       86       55       32       12        9 
degree16 degree17 degree18 
       3        1        1 
1 
disease_progression 
H-positive risk:  870 841 120 855 475 129 898 436 112 55 130 79 
H-negative risk:  841 870 898 855 436 475 129 120 130 112 79 55 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
60 new agents 
2 
disease_progression 
H-positive risk:  878 845 120 858 471 133 890 435 111 51 130 78 
H-negative risk:  845 878 890 858 435 471 133 120 130 111 78 51 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
61 new agents 
3 
disease_progression 
H-positive risk:  883 853 123 856 474 133 883 431 108 51 128 77 
H-negative risk:  853 883 883 856 431 474 133 123 128 108 77 51 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
61 new agents 
4 
disease_progression 
H-positive risk:  888 858 123 853 471 133 890 421 109 49 126 79 
H-negative risk:  858 888 890 853 421 471 133 123 126 109 79 49 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 5 3 

clinical_engagement 
diagnosis 
demography 
53 new agents 
5 
disease_progression 
H-positive risk:  895 859 126 856 463 134 895 411 106 49 126 80 
H-negative risk:  859 895 895 856 411 463 134 126 126 106 80 49 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 5 3 

clinical_engagement 
diagnosis 
demography 
51 new agents 
6 
disease_progression 
H-positive risk:  899 864 126 857 458 132 892 407 107 50 128 80 
H-negative risk:  864 899 892 857 407 458 132 126 128 107 80 50 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 7 5 

clinical_engagement 
diagnosis 
demography 
49 new agents 
7 
disease_progression 
H-positive risk:  905 866 127 856 456 133 884 407 106 50 130 80 
H-negative risk:  866 905 884 856 407 456 133 127 130 106 80 50 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 7 5 

clinical_engagement 
diagnosis 
demography 
65 new agents 
8 
disease_progression 
H-positive risk:  908 870 128 860 449 134 883 402 107 50 131 78 
H-negative risk:  870 908 883 860 402 449 134 128 131 107 78 50 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 11 5 

clinical_engagement 
diagnosis 
demography 
68 new agents 
9 
disease_progression 
H-positive risk:  916 874 130 855 451 135 878 398 107 52 128 76 
H-negative risk:  874 916 878 855 398 451 135 130 128 107 76 52 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 11 6 

clinical_engagement 
diagnosis 
demography 
63 new agents 
10 
disease_progression 
H-positive risk:  918 882 131 855 446 136 874 395 107 53 129 74 
H-negative risk:  882 918 874 855 395 446 136 131 129 107 74 53 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 13 6 

clinical_engagement 
diagnosis 
demography 
58 new agents 
11 
disease_progression 
H-positive risk:  925 892 131 854 443 137 870 392 105 51 127 73 
H-negative risk:  892 925 870 854 392 443 137 131 127 105 73 51 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 15 7 

clinical_engagement 
diagnosis 
demography 
68 new agents 
12 
disease_progression 
H-positive risk:  931 896 132 852 439 137 877 380 106 51 128 71 
H-negative risk:  896 931 877 852 380 439 137 132 128 106 71 51 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 20 8 

clinical_engagement 
diagnosis 
demography 
57 new agents 
13 
disease_progression 
H-positive risk:  856 823 120 931 434 126 959 374 117 51 138 71 
H-negative risk:  823 856 959 931 374 434 126 120 138 117 71 51 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 21 8 

clinical_engagement 
diagnosis 
demography 
211 new agents 
14 
disease_progression 
H-positive risk:  886 853 123 885 448 124 937 388 111 50 133 62 
H-negative risk:  853 886 937 885 388 448 124 123 133 111 62 50 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 24 8 

clinical_engagement 
diagnosis 
demography 
60 new agents 
15 
disease_progression 
H-positive risk:  886 860 125 889 438 123 937 385 112 49 132 64 
H-negative risk:  860 886 937 889 385 438 123 125 132 112 64 49 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 25 7 

clinical_engagement 
diagnosis 
demography 
64 new agents 
16 
disease_progression 
H-positive risk:  889 860 127 885 436 125 937 380 113 51 133 64 
H-negative risk:  860 889 937 885 380 436 125 127 133 113 64 51 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 28 7 

clinical_engagement 
diagnosis 
demography 
57 new agents 
17 
disease_progression 
H-positive risk:  895 861 126 880 428 127 949 377 112 48 136 61 
H-negative risk:  861 895 949 880 377 428 127 126 136 112 61 48 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 29 7 

clinical_engagement 
diagnosis 
demography 
74 new agents 
18 
disease_progression 
H-positive risk:  901 869 127 883 420 125 947 372 114 50 132 60 
H-negative risk:  869 901 947 883 372 420 125 127 132 114 60 50 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 30 7 

clinical_engagement 
diagnosis 
demography 
60 new agents 
19 
disease_progression 
H-positive risk:  905 872 128 883 417 124 945 372 113 50 132 59 
H-negative risk:  872 905 945 883 372 417 124 128 132 113 59 50 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 30 10 

clinical_engagement 
diagnosis 
demography 
52 new agents 
20 
disease_progression 
H-positive risk:  912 877 128 879 418 123 945 370 110 51 129 58 
H-negative risk:  877 912 945 879 370 418 123 128 129 110 58 51 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 32 10 

clinical_engagement 
diagnosis 
demography 
57 new agents 
21 
disease_progression 
H-positive risk:  921 876 127 887 412 125 941 362 111 51 130 57 
H-negative risk:  876 921 941 887 362 412 125 127 130 111 57 51 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 34 10 

clinical_engagement 
diagnosis 
demography 
61 new agents 
22 
disease_progression 
H-positive risk:  920 878 127 886 407 128 948 359 110 51 128 58 
H-negative risk:  878 920 948 886 359 407 128 127 128 110 58 51 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 35 10 

clinical_engagement 
diagnosis 
demography 
61 new agents 
23 
disease_progression 
H-positive risk:  921 880 126 889 393 126 953 364 112 53 125 58 
H-negative risk:  880 921 953 889 364 393 126 126 125 112 58 53 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 35 11 

clinical_engagement 
diagnosis 
demography 
59 new agents 
24 
disease_progression 
H-positive risk:  927 885 127 890 394 127 948 360 111 52 122 57 
H-negative risk:  885 927 948 890 360 394 127 127 122 111 57 52 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 36 12 

clinical_engagement 
diagnosis 
demography 
49 new agents 
25 
disease_progression 
H-positive risk:  859 845 115 933 391 115 1022 357 124 52 130 57 
H-negative risk:  845 859 1022 933 357 391 115 115 130 124 57 52 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 38 12 

clinical_engagement 
diagnosis 
demography 
204 new agents 
26 
disease_progression 
H-positive risk:  879 865 118 910 392 116 979 388 120 55 128 50 
H-negative risk:  865 879 979 910 388 392 116 118 128 120 50 55 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 44 12 

clinical_engagement 
diagnosis 
demography 
71 new agents 
27 
disease_progression 
H-positive risk:  883 864 119 907 389 118 973 394 119 56 128 50 
H-negative risk:  864 883 973 907 394 389 118 119 128 119 50 56 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 43 13 

clinical_engagement 
diagnosis 
demography 
79 new agents 
28 
disease_progression 
H-positive risk:  886 873 119 906 381 119 967 396 116 56 130 51 
H-negative risk:  873 886 967 906 396 381 119 119 130 116 51 56 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 42 13 

clinical_engagement 
diagnosis 
demography 
72 new agents 
29 
disease_progression 
H-positive risk:  896 879 116 907 374 120 971 388 115 56 129 49 
H-negative risk:  879 896 971 907 388 374 120 116 129 115 49 56 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 44 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
30 
disease_progression 
H-positive risk:  894 882 116 899 371 120 978 388 115 56 131 50 
H-negative risk:  882 894 978 899 388 371 120 116 131 115 50 56 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 45 13 

clinical_engagement 
diagnosis 
demography 
70 new agents 
31 
disease_progression 
H-positive risk:  897 892 119 897 370 121 969 386 113 56 131 49 
H-negative risk:  892 897 969 897 386 370 121 119 131 113 49 56 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 47 13 

clinical_engagement 
diagnosis 
demography 
65 new agents 
32 
disease_progression 
H-positive risk:  908 899 121 893 367 121 972 372 112 55 131 49 
H-negative risk:  899 908 972 893 372 367 121 121 131 112 49 55 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 51 12 

clinical_engagement 
diagnosis 
demography 
67 new agents 
33 
disease_progression 
H-positive risk:  912 907 122 897 363 120 967 373 109 54 128 48 
H-negative risk:  907 912 967 897 373 363 120 122 128 109 48 54 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 50 12 

clinical_engagement 
diagnosis 
demography 
60 new agents 
34 
disease_progression 
H-positive risk:  915 912 123 899 354 118 970 373 110 50 129 47 
H-negative risk:  912 915 970 899 373 354 118 123 129 110 47 50 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 53 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
35 
disease_progression 
H-positive risk:  922 918 125 899 353 118 962 370 107 51 129 46 
H-negative risk:  918 922 962 899 370 353 118 125 129 107 46 51 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 53 16 

clinical_engagement 
diagnosis 
demography 
54 new agents 
36 
disease_progression 
H-positive risk:  923 924 121 902 350 116 965 363 108 50 131 47 
H-negative risk:  924 923 965 902 363 350 116 121 131 108 47 50 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 55 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
37 
disease_progression 
H-positive risk:  873 862 108 971 345 105 1021 362 120 46 139 48 
H-negative risk:  862 873 1021 971 362 345 105 108 139 120 48 46 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 59 16 

clinical_engagement 
diagnosis 
demography 
142 new agents 
38 
disease_progression 
H-positive risk:  886 871 111 956 352 110 997 367 118 48 130 54 
H-negative risk:  871 886 997 956 367 352 110 111 130 118 54 48 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 61 16 

clinical_engagement 
diagnosis 
demography 
86 new agents 
39 
disease_progression 
H-positive risk:  887 874 113 955 352 113 1002 362 113 44 130 55 
H-negative risk:  874 887 1002 955 362 352 113 113 130 113 55 44 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 64 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
40 
disease_progression 
H-positive risk:  883 877 114 956 354 111 1007 356 116 44 130 52 
H-negative risk:  877 883 1007 956 356 354 111 114 130 116 52 44 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 64 16 

clinical_engagement 
diagnosis 
demography 
58 new agents 
41 
disease_progression 
H-positive risk:  888 880 114 956 350 113 998 360 117 46 129 49 
H-negative risk:  880 888 998 956 360 350 113 114 129 117 49 46 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 64 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
42 
disease_progression 
H-positive risk:  888 888 113 963 344 114 989 364 118 43 129 47 
H-negative risk:  888 888 989 963 364 344 114 113 129 118 47 43 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 63 17 

clinical_engagement 
diagnosis 
demography 
61 new agents 
43 
disease_progression 
H-positive risk:  891 895 114 959 343 115 988 359 117 44 129 46 
H-negative risk:  895 891 988 959 359 343 115 114 129 117 46 44 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 63 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
44 
disease_progression 
H-positive risk:  892 904 114 957 342 116 981 353 117 45 132 47 
H-negative risk:  904 892 981 957 353 342 116 114 132 117 47 45 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 64 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
45 
disease_progression 
H-positive risk:  894 911 114 959 341 116 976 352 117 43 132 45 
H-negative risk:  911 894 976 959 352 341 116 114 132 117 45 43 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 65 18 

clinical_engagement 
diagnosis 
demography 
55 new agents 
46 
disease_progression 
H-positive risk:  892 910 115 962 344 116 975 352 118 41 129 46 
H-negative risk:  910 892 975 962 352 344 116 115 129 118 46 41 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 64 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
47 
disease_progression 
H-positive risk:  887 915 117 961 341 117 976 355 118 40 129 44 
H-negative risk:  915 887 976 961 355 341 117 117 129 118 44 40 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
42 new agents 
48 
disease_progression 
H-positive risk:  884 913 117 961 343 118 976 356 120 40 130 42 
H-negative risk:  913 884 976 961 356 343 118 117 130 120 42 40 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
49 
disease_progression 
H-positive risk:  828 863 111 1015 340 104 1016 367 139 42 135 40 
H-negative risk:  863 828 1016 1015 367 340 104 111 135 139 40 42 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 67 17 

clinical_engagement 
diagnosis 
demography 
130 new agents 
50 
disease_progression 
H-positive risk:  829 870 110 993 357 106 996 389 137 41 132 40 
H-negative risk:  870 829 996 993 389 357 106 110 132 137 40 41 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 69 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
51 
disease_progression 
H-positive risk:  823 875 112 988 361 107 992 389 140 43 128 42 
H-negative risk:  875 823 992 988 389 361 107 112 128 140 42 43 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 70 17 

clinical_engagement 
diagnosis 
demography 
61 new agents 
52 
disease_progression 
H-positive risk:  831 878 111 983 359 105 990 396 136 43 127 41 
H-negative risk:  878 831 990 983 396 359 105 111 127 136 41 43 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
53 
disease_progression 
H-positive risk:  831 884 112 982 354 110 981 398 137 43 127 41 
H-negative risk:  884 831 981 982 398 354 110 112 127 137 41 43 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
54 
disease_progression 
H-positive risk:  835 885 112 982 357 112 975 393 137 44 127 41 
H-negative risk:  885 835 975 982 393 357 112 112 127 137 41 44 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
55 
disease_progression 
H-positive risk:  843 886 113 976 360 111 968 394 136 45 128 40 
H-negative risk:  886 843 968 976 394 360 111 113 128 136 40 45 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
45 new agents 
56 
disease_progression 
H-positive risk:  844 879 112 981 366 111 971 387 137 46 127 39 
H-negative risk:  879 844 971 981 387 366 111 112 127 137 39 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
57 
disease_progression 
H-positive risk:  843 874 112 982 368 109 978 387 139 45 127 36 
H-negative risk:  874 843 978 982 387 368 109 112 127 139 36 45 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
58 
disease_progression 
H-positive risk:  842 880 111 989 368 108 978 376 143 44 125 36 
H-negative risk:  880 842 978 989 376 368 108 111 125 143 36 44 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
54 new agents 
59 
disease_progression 
H-positive risk:  845 876 109 985 369 108 971 386 143 44 128 36 
H-negative risk:  876 845 971 985 386 369 108 109 128 143 36 44 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
60 
disease_progression 
H-positive risk:  846 877 109 978 367 107 980 382 145 45 128 36 
H-negative risk:  877 846 980 978 382 367 107 109 128 145 36 45 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
61 
disease_progression 
H-positive risk:  800 820 105 1024 363 99 1031 390 152 44 134 38 
H-negative risk:  820 800 1031 1024 390 363 99 105 134 152 38 44 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
117 new agents 
62 
disease_progression 
H-positive risk:  796 824 104 1012 368 102 1026 396 151 45 139 37 
H-negative risk:  824 796 1026 1012 396 368 102 104 139 151 37 45 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
63 
disease_progression 
H-positive risk:  806 829 108 998 376 101 1027 385 147 48 141 34 
H-negative risk:  829 806 1027 998 385 376 101 108 141 147 34 48 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
64 
disease_progression 
H-positive risk:  803 833 108 1007 374 102 1019 384 147 49 139 35 
H-negative risk:  833 803 1019 1007 384 374 102 108 139 147 35 49 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
53 new agents 
65 
disease_progression 
H-positive risk:  801 840 108 1009 365 101 1014 388 146 51 142 35 
H-negative risk:  840 801 1014 1009 388 365 101 108 142 146 35 51 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
66 
disease_progression 
H-positive risk:  804 839 109 1008 367 101 1015 382 144 50 143 38 
H-negative risk:  839 804 1015 1008 382 367 101 109 143 144 38 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
67 
disease_progression 
H-positive risk:  811 839 111 997 365 101 1018 382 143 51 143 39 
H-negative risk:  839 811 1018 997 382 365 101 111 143 143 39 51 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
68 
disease_progression 
H-positive risk:  822 842 109 996 359 98 1017 389 140 46 142 40 
H-negative risk:  842 822 1017 996 389 359 98 109 142 140 40 46 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
69 
disease_progression 
H-positive risk:  827 839 108 997 356 100 1018 384 142 44 145 40 
H-negative risk:  839 827 1018 997 384 356 100 108 145 142 40 44 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
70 
disease_progression 
H-positive risk:  821 844 111 999 359 99 1021 377 138 45 144 42 
H-negative risk:  844 821 1021 999 377 359 99 111 144 138 42 45 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
71 
disease_progression 
H-positive risk:  825 853 110 999 362 100 1004 379 140 43 143 42 
H-negative risk:  853 825 1004 999 379 362 100 110 143 140 42 43 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
55 new agents 
72 
disease_progression 
H-positive risk:  824 853 111 999 367 102 1002 380 134 42 144 42 
H-negative risk:  853 824 1002 999 380 367 102 111 144 134 42 42 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
73 
disease_progression 
H-positive risk:  786 801 104 1055 355 95 1038 384 143 43 149 47 
H-negative risk:  801 786 1038 1055 384 355 95 104 149 143 47 43 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
137 new agents 
74 
disease_progression 
H-positive risk:  790 797 105 1051 368 96 1011 398 145 45 144 50 
H-negative risk:  797 790 1011 1051 398 368 96 105 144 145 50 45 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 67 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
75 
disease_progression 
H-positive risk:  788 802 103 1044 380 96 1006 403 144 42 145 47 
H-negative risk:  802 788 1006 1044 403 380 96 103 145 144 47 42 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
76 
disease_progression 
H-positive risk:  788 810 102 1036 378 95 1008 406 143 45 143 46 
H-negative risk:  810 788 1008 1036 406 378 95 102 143 143 46 45 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 67 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
77 
disease_progression 
H-positive risk:  781 808 102 1037 383 97 1012 394 148 43 146 49 
H-negative risk:  808 781 1012 1037 394 383 97 102 146 148 49 43 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
78 
disease_progression 
H-positive risk:  790 807 100 1041 378 95 1011 397 145 42 145 49 
H-negative risk:  807 790 1011 1041 397 378 95 100 145 145 49 42 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 67 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
79 
disease_progression 
H-positive risk:  790 808 102 1036 385 94 1007 388 146 44 151 49 
H-negative risk:  808 790 1007 1036 388 385 94 102 151 146 49 44 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
80 
disease_progression 
H-positive risk:  787 813 103 1034 383 94 1008 388 148 42 153 47 
H-negative risk:  813 787 1008 1034 388 383 94 103 153 148 47 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 66 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
81 
disease_progression 
H-positive risk:  803 811 103 1028 377 92 1012 386 147 41 150 50 
H-negative risk:  811 803 1012 1028 386 377 92 103 150 147 50 41 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 64 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
82 
disease_progression 
H-positive risk:  801 813 102 1032 370 91 1017 384 148 41 151 50 
H-negative risk:  813 801 1017 1032 384 370 91 102 151 148 50 41 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 64 30 

clinical_engagement 
diagnosis 
demography 
86 new agents 
83 
disease_progression 
H-positive risk:  795 811 102 1029 366 91 1027 384 151 42 153 49 
H-negative risk:  811 795 1027 1029 384 366 91 102 153 151 49 42 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 61 32 

clinical_engagement 
diagnosis 
demography 
61 new agents 
84 
disease_progression 
H-positive risk:  792 811 99 1032 365 92 1027 383 153 43 153 50 
H-negative risk:  811 792 1027 1032 383 365 92 99 153 153 50 43 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 60 31 

clinical_engagement 
diagnosis 
demography 
58 new agents 
85 
disease_progression 
H-positive risk:  753 767 94 1073 362 86 1062 390 158 45 162 48 
H-negative risk:  767 753 1062 1073 390 362 86 94 162 158 48 45 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 60 34 

clinical_engagement 
diagnosis 
demography 
111 new agents 
86 
disease_progression 
H-positive risk:  756 773 97 1056 379 89 1044 401 151 44 157 53 
H-negative risk:  773 756 1044 1056 401 379 89 97 157 151 53 44 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 62 33 

clinical_engagement 
diagnosis 
demography 
90 new agents 
87 
disease_progression 
H-positive risk:  756 776 97 1048 382 90 1042 407 150 43 155 54 
H-negative risk:  776 756 1042 1048 407 382 90 97 155 150 54 43 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 66 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
88 
disease_progression 
H-positive risk:  764 773 98 1047 383 93 1036 403 154 39 156 54 
H-negative risk:  773 764 1036 1047 403 383 93 98 156 154 54 39 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 65 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
89 
disease_progression 
H-positive risk:  773 766 101 1053 382 92 1029 401 155 37 156 55 
H-negative risk:  766 773 1029 1053 401 382 92 101 156 155 55 37 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 61 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
90 
disease_progression 
H-positive risk:  777 775 101 1049 383 89 1031 389 157 39 153 57 
H-negative risk:  775 777 1031 1049 389 383 89 101 153 157 57 39 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 62 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
91 
disease_progression 
H-positive risk:  785 773 101 1045 383 90 1035 384 153 40 155 56 
H-negative risk:  773 785 1035 1045 384 383 90 101 155 153 56 40 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 62 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
92 
disease_progression 
H-positive risk:  780 778 98 1041 379 91 1039 387 154 39 159 55 
H-negative risk:  778 780 1039 1041 387 379 91 98 159 154 55 39 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 62 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
93 
disease_progression 
H-positive risk:  784 774 99 1052 377 90 1040 378 157 37 159 53 
H-negative risk:  774 784 1040 1052 378 377 90 99 159 157 53 37 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 62 29 

clinical_engagement 
diagnosis 
demography 
66 new agents 
94 
disease_progression 
H-positive risk:  787 771 98 1061 375 91 1035 375 158 38 159 52 
H-negative risk:  771 787 1035 1061 375 375 91 98 159 158 52 38 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 65 29 

clinical_engagement 
diagnosis 
demography 
88 new agents 
95 
disease_progression 
H-positive risk:  783 775 96 1055 370 92 1042 371 158 42 163 53 
H-negative risk:  775 783 1042 1055 371 370 92 96 163 158 53 42 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
96 
disease_progression 
H-positive risk:  786 777 98 1049 366 95 1040 374 157 41 163 54 
H-negative risk:  777 786 1040 1049 374 366 95 98 163 157 54 41 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
97 
disease_progression 
H-positive risk:  739 747 96 1086 363 89 1090 371 160 41 164 54 
H-negative risk:  747 739 1090 1086 371 363 89 96 164 160 54 41 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
109 new agents 
98 
disease_progression 
H-positive risk:  747 752 98 1052 392 95 1067 384 155 43 165 50 
H-negative risk:  752 747 1067 1052 384 392 95 98 165 155 50 43 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
99 
disease_progression 
H-positive risk:  746 749 99 1052 395 96 1069 385 154 44 166 45 
H-negative risk:  749 746 1069 1052 385 395 96 99 166 154 45 44 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
100 
disease_progression 
H-positive risk:  745 749 99 1059 388 96 1068 384 153 47 167 45 
H-negative risk:  749 745 1068 1059 384 388 96 99 167 153 45 47 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
101 
disease_progression 
H-positive risk:  744 745 100 1059 392 97 1071 379 154 45 169 45 
H-negative risk:  745 744 1071 1059 379 392 97 100 169 154 45 45 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
102 
disease_progression 
H-positive risk:  744 747 99 1062 389 95 1068 376 154 50 169 47 
H-negative risk:  747 744 1068 1062 376 389 95 99 169 154 47 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
55 new agents 
103 
disease_progression 
H-positive risk:  744 750 98 1065 386 92 1069 380 154 49 169 44 
H-negative risk:  750 744 1069 1065 380 386 92 98 169 154 44 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
104 
disease_progression 
H-positive risk:  747 743 99 1071 393 94 1066 376 155 47 164 45 
H-negative risk:  743 747 1066 1071 376 393 94 99 164 155 45 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
105 
disease_progression 
H-positive risk:  746 743 100 1067 397 92 1067 379 153 46 165 45 
H-negative risk:  743 746 1067 1067 379 397 92 100 165 153 45 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
106 
disease_progression 
H-positive risk:  750 740 100 1058 403 92 1069 382 153 44 164 45 
H-negative risk:  740 750 1069 1058 382 403 92 100 164 153 45 44 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
107 
disease_progression 
H-positive risk:  747 735 98 1060 410 90 1079 376 154 43 164 44 
H-negative risk:  735 747 1079 1060 376 410 90 98 164 154 44 43 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
59 new agents 
108 
disease_progression 
H-positive risk:  744 736 98 1059 411 93 1079 376 154 43 162 45 
H-negative risk:  736 744 1079 1059 376 411 93 98 162 154 45 43 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
109 
disease_progression 
H-positive risk:  701 677 93 1111 408 86 1136 380 158 45 163 42 
H-negative risk:  677 701 1136 1111 380 408 86 93 163 158 42 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
112 new agents 
110 
disease_progression 
H-positive risk:  696 676 93 1101 422 87 1125 386 160 47 161 46 
H-negative risk:  676 696 1125 1101 386 422 87 93 161 160 46 47 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
111 
disease_progression 
H-positive risk:  696 670 91 1110 423 88 1112 401 155 47 159 48 
H-negative risk:  670 696 1112 1110 401 423 88 91 159 155 48 47 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
112 
disease_progression 
H-positive risk:  689 668 94 1113 426 88 1111 400 157 45 160 49 
H-negative risk:  668 689 1111 1113 400 426 88 94 160 157 49 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
113 
disease_progression 
H-positive risk:  684 669 93 1105 430 90 1114 399 160 43 163 50 
H-negative risk:  669 684 1114 1105 399 430 90 93 163 160 50 43 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
114 
disease_progression 
H-positive risk:  684 675 90 1105 431 92 1106 400 161 42 164 50 
H-negative risk:  675 684 1106 1105 400 431 92 90 164 161 50 42 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
115 
disease_progression 
H-positive risk:  682 669 93 1104 428 91 1120 399 162 42 161 49 
H-negative risk:  669 682 1120 1104 399 428 91 93 161 162 49 42 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
116 
disease_progression 
H-positive risk:  683 681 93 1101 424 93 1120 398 161 39 159 48 
H-negative risk:  681 683 1120 1101 398 424 93 93 159 161 48 39 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
117 
disease_progression 
H-positive risk:  678 688 93 1102 419 96 1128 394 159 39 157 47 
H-negative risk:  688 678 1128 1102 394 419 96 93 157 159 47 39 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
118 
disease_progression 
H-positive risk:  687 687 92 1099 411 96 1127 397 159 40 156 49 
H-negative risk:  687 687 1127 1099 397 411 96 92 156 159 49 40 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
119 
disease_progression 
H-positive risk:  681 694 92 1092 416 99 1130 391 161 40 157 47 
H-negative risk:  694 681 1130 1092 391 416 99 92 157 161 47 40 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
56 new agents 
120 
disease_progression 
H-positive risk:  685 697 91 1088 419 100 1125 385 161 42 159 48 
H-negative risk:  697 685 1125 1088 385 419 100 91 159 161 48 42 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
121 
disease_progression 
H-positive risk:  643 665 85 1126 419 93 1176 380 161 42 161 49 
H-negative risk:  665 643 1176 1126 380 419 93 85 161 161 49 42 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
92 new agents 
122 
disease_progression 
H-positive risk:  638 667 85 1109 431 93 1174 392 160 41 158 52 
H-negative risk:  667 638 1174 1109 392 431 93 85 158 160 52 41 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
123 
disease_progression 
H-positive risk:  636 664 85 1107 430 94 1168 402 160 43 157 54 
H-negative risk:  664 636 1168 1107 402 430 94 85 157 160 54 43 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
124 
disease_progression 
H-positive risk:  637 664 83 1114 431 94 1167 396 161 40 159 54 
H-negative risk:  664 637 1167 1114 396 431 94 83 159 161 54 40 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
91 new agents 
125 
disease_progression 
H-positive risk:  635 671 82 1113 429 96 1166 388 163 40 164 53 
H-negative risk:  671 635 1166 1113 388 429 96 82 164 163 53 40 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
126 
disease_progression 
H-positive risk:  632 674 83 1127 425 96 1165 387 159 39 161 52 
H-negative risk:  674 632 1165 1127 387 425 96 83 161 159 52 39 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
127 
disease_progression 
H-positive risk:  635 671 80 1134 420 97 1162 389 161 38 161 52 
H-negative risk:  671 635 1162 1134 389 420 97 80 161 161 52 38 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
57 new agents 
128 
disease_progression 
H-positive risk:  638 670 83 1132 419 98 1163 388 162 35 160 52 
H-negative risk:  670 638 1163 1132 388 419 98 83 160 162 52 35 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
129 
disease_progression 
H-positive risk:  630 669 85 1130 417 98 1179 380 162 36 161 53 
H-negative risk:  669 630 1179 1130 380 417 98 85 161 162 53 36 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
130 
disease_progression 
H-positive risk:  639 672 87 1119 418 99 1178 384 157 35 159 53 
H-negative risk:  672 639 1178 1119 384 418 99 87 159 157 53 35 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
131 
disease_progression 
H-positive risk:  642 666 91 1131 420 99 1166 385 155 35 160 50 
H-negative risk:  666 642 1166 1131 385 420 99 91 160 155 50 35 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
132 
disease_progression 
H-positive risk:  654 673 88 1128 414 98 1160 381 158 37 159 50 
H-negative risk:  673 654 1160 1128 381 414 98 88 159 158 50 37 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
133 
disease_progression 
H-positive risk:  658 672 90 1125 406 99 1167 378 160 36 159 50 
H-negative risk:  672 658 1167 1125 378 406 99 90 159 160 50 36 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
134 
disease_progression 
H-positive risk:  650 664 86 1129 412 97 1162 388 163 37 161 51 
H-negative risk:  664 650 1162 1129 388 412 97 86 161 163 51 37 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
135 
disease_progression 
H-positive risk:  645 666 83 1129 405 98 1168 392 164 37 164 49 
H-negative risk:  666 645 1168 1129 392 405 98 83 164 164 49 37 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
136 
disease_progression 
H-positive risk:  647 667 82 1128 408 98 1167 388 165 39 163 48 
H-negative risk:  667 647 1167 1128 388 408 98 82 163 165 48 39 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
137 
disease_progression 
H-positive risk:  647 661 82 1124 408 98 1172 392 164 40 161 51 
H-negative risk:  661 647 1172 1124 392 408 98 82 161 164 51 40 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
138 
disease_progression 
H-positive risk:  643 657 83 1117 417 100 1182 386 165 40 159 51 
H-negative risk:  657 643 1182 1117 386 417 100 83 159 165 51 40 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
139 
disease_progression 
H-positive risk:  645 656 83 1119 416 101 1185 380 165 39 159 52 
H-negative risk:  656 645 1185 1119 380 416 101 83 159 165 52 39 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
140 
disease_progression 
H-positive risk:  636 657 82 1123 409 99 1186 386 170 39 162 51 
H-negative risk:  657 636 1186 1123 386 409 99 82 162 170 51 39 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
141 
disease_progression 
H-positive risk:  645 652 84 1136 402 102 1181 382 166 39 163 48 
H-negative risk:  652 645 1181 1136 382 402 102 84 163 166 48 39 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
142 
disease_progression 
H-positive risk:  648 651 86 1142 397 101 1174 384 169 39 163 46 
H-negative risk:  651 648 1174 1142 384 397 101 86 163 169 46 39 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
94 new agents 
143 
disease_progression 
H-positive risk:  655 645 85 1151 393 103 1166 382 168 39 164 49 
H-negative risk:  645 655 1166 1151 382 393 103 85 164 168 49 39 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
144 
disease_progression 
H-positive risk:  661 636 86 1161 390 106 1161 384 168 37 161 49 
H-negative risk:  636 661 1161 1161 384 390 106 86 161 168 49 37 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
145 
disease_progression 
H-positive risk:  658 641 86 1157 390 107 1155 394 166 36 160 50 
H-negative risk:  641 658 1155 1157 394 390 107 86 160 166 50 36 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
146 
disease_progression 
H-positive risk:  661 638 87 1168 383 106 1142 403 160 42 161 49 
H-negative risk:  638 661 1142 1168 403 383 106 87 161 160 49 42 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
147 
disease_progression 
H-positive risk:  663 645 85 1168 375 108 1139 409 157 40 159 52 
H-negative risk:  645 663 1139 1168 409 375 108 85 159 157 52 40 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
148 
disease_progression 
H-positive risk:  666 655 84 1158 386 109 1132 406 153 42 159 50 
H-negative risk:  655 666 1132 1158 406 386 109 84 159 153 50 42 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
149 
disease_progression 
H-positive risk:  657 660 87 1161 385 112 1135 401 156 43 155 48 
H-negative risk:  660 657 1135 1161 401 385 112 87 155 156 48 43 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 64 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
150 
disease_progression 
H-positive risk:  657 659 90 1161 387 112 1128 404 159 44 154 45 
H-negative risk:  659 657 1128 1161 404 387 112 90 154 159 45 44 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
91 new agents 
151 
disease_progression 
H-positive risk:  654 660 84 1166 389 110 1130 398 160 45 158 46 
H-negative risk:  660 654 1130 1166 398 389 110 84 158 160 46 45 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 65 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
152 
disease_progression 
H-positive risk:  657 660 86 1166 388 111 1133 393 162 43 155 46 
H-negative risk:  660 657 1133 1166 393 388 111 86 155 162 46 43 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 63 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
153 
disease_progression 
H-positive risk:  657 656 86 1173 382 108 1143 385 164 43 155 48 
H-negative risk:  656 657 1143 1173 385 382 108 86 155 164 48 43 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 62 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
154 
disease_progression 
H-positive risk:  660 660 84 1162 381 109 1145 388 164 42 157 48 
H-negative risk:  660 660 1145 1162 388 381 109 84 157 164 48 42 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 62 23 

clinical_engagement 
diagnosis 
demography 
55 new agents 
155 
disease_progression 
H-positive risk:  657 666 84 1157 386 109 1145 384 165 41 158 48 
H-negative risk:  666 657 1145 1157 384 386 109 84 158 165 48 41 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
156 
disease_progression 
H-positive risk:  657 671 83 1153 377 109 1154 381 166 38 163 48 
H-negative risk:  671 657 1154 1153 381 377 109 83 163 166 48 38 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
157 
disease_progression 
H-positive risk:  664 665 82 1157 371 110 1152 385 163 38 164 49 
H-negative risk:  665 664 1152 1157 385 371 110 82 164 163 49 38 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
158 
disease_progression 
H-positive risk:  668 667 84 1158 376 105 1135 393 161 40 164 49 
H-negative risk:  667 668 1135 1158 393 376 105 84 164 161 49 40 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 62 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
159 
disease_progression 
H-positive risk:  667 664 83 1154 381 103 1137 398 158 42 164 49 
H-negative risk:  664 667 1137 1154 398 381 103 83 164 158 49 42 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 64 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
160 
disease_progression 
H-positive risk:  667 672 82 1142 380 107 1141 398 158 41 159 53 
H-negative risk:  672 667 1141 1142 398 380 107 82 159 158 53 41 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 64 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
161 
disease_progression 
H-positive risk:  668 666 77 1150 383 106 1138 396 159 42 157 58 
H-negative risk:  666 668 1138 1150 396 383 106 77 157 159 58 42 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 62 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
162 
disease_progression 
H-positive risk:  668 664 76 1150 389 107 1131 399 157 43 157 59 
H-negative risk:  664 668 1131 1150 399 389 107 76 157 157 59 43 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
163 
disease_progression 
H-positive risk:  659 661 74 1149 382 108 1147 401 155 44 160 60 
H-negative risk:  661 659 1147 1149 401 382 108 74 160 155 60 44 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
164 
disease_progression 
H-positive risk:  654 671 75 1146 384 110 1138 404 156 43 160 59 
H-negative risk:  671 654 1138 1146 404 384 110 75 160 156 59 43 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 64 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
165 
disease_progression 
H-positive risk:  656 667 80 1149 385 109 1137 396 158 43 161 59 
H-negative risk:  667 656 1137 1149 396 385 109 80 161 158 59 43 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 61 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
166 
disease_progression 
H-positive risk:  653 665 78 1147 386 110 1139 398 157 45 160 62 
H-negative risk:  665 653 1139 1147 398 386 110 78 160 157 62 45 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 63 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
167 
disease_progression 
H-positive risk:  656 664 76 1141 392 111 1138 396 158 45 161 62 
H-negative risk:  664 656 1138 1141 396 392 111 76 161 158 62 45 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 64 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
168 
disease_progression 
H-positive risk:  655 666 75 1138 390 107 1138 399 159 49 160 64 
H-negative risk:  666 655 1138 1138 399 390 107 75 160 159 64 49 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 64 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
169 
disease_progression 
H-positive risk:  659 662 76 1143 390 109 1133 401 157 46 161 63 
H-negative risk:  662 659 1133 1143 401 390 109 76 161 157 63 46 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
170 
disease_progression 
H-positive risk:  659 669 76 1142 389 107 1119 404 156 50 162 67 
H-negative risk:  669 659 1119 1142 404 389 107 76 162 156 67 50 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
171 
disease_progression 
H-positive risk:  662 670 78 1148 389 103 1114 404 155 51 158 68 
H-negative risk:  670 662 1114 1148 404 389 103 78 158 155 68 51 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
172 
disease_progression 
H-positive risk:  666 663 80 1144 388 104 1120 404 152 51 158 70 
H-negative risk:  663 666 1120 1144 404 388 104 80 158 152 70 51 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
173 
disease_progression 
H-positive risk:  669 661 82 1143 392 105 1116 403 151 54 156 68 
H-negative risk:  661 669 1116 1143 403 392 105 82 156 151 68 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
174 
disease_progression 
H-positive risk:  668 654 81 1151 392 105 1111 405 152 55 159 67 
H-negative risk:  654 668 1111 1151 405 392 105 81 159 152 67 55 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
175 
disease_progression 
H-positive risk:  670 652 82 1150 394 107 1118 399 150 54 159 65 
H-negative risk:  652 670 1118 1150 399 394 107 82 159 150 65 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
176 
disease_progression 
H-positive risk:  669 649 80 1161 390 109 1117 401 147 52 161 64 
H-negative risk:  649 669 1117 1161 401 390 109 80 161 147 64 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
177 
disease_progression 
H-positive risk:  667 658 82 1156 389 109 1114 402 146 53 159 65 
H-negative risk:  658 667 1114 1156 402 389 109 82 159 146 65 53 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
178 
disease_progression 
H-positive risk:  666 655 81 1158 389 109 1120 397 145 53 161 66 
H-negative risk:  655 666 1120 1158 397 389 109 81 161 145 66 53 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
179 
disease_progression 
H-positive risk:  665 654 83 1146 389 105 1127 401 145 55 163 67 
H-negative risk:  654 665 1127 1146 401 389 105 83 163 145 67 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
180 
disease_progression 
H-positive risk:  665 659 84 1137 397 104 1129 403 140 55 159 68 
H-negative risk:  659 665 1129 1137 403 397 104 84 159 140 68 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
181 
disease_progression 
H-positive risk:  664 666 83 1135 391 105 1142 397 138 52 158 69 
H-negative risk:  666 664 1142 1135 397 391 105 83 158 138 69 52 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
182 
disease_progression 
H-positive risk:  662 674 81 1133 386 105 1140 402 135 55 159 68 
H-negative risk:  674 662 1140 1133 402 386 105 81 159 135 68 55 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
183 
disease_progression 
H-positive risk:  661 675 77 1132 388 105 1133 407 136 54 164 68 
H-negative risk:  675 661 1133 1132 407 388 105 77 164 136 68 54 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
184 
disease_progression 
H-positive risk:  669 680 81 1128 384 102 1123 410 138 56 162 67 
H-negative risk:  680 669 1123 1128 410 384 102 81 162 138 67 56 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
185 
disease_progression 
H-positive risk:  672 677 83 1110 388 101 1134 413 139 55 159 69 
H-negative risk:  677 672 1134 1110 413 388 101 83 159 139 69 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
186 
disease_progression 
H-positive risk:  678 675 80 1107 393 100 1134 404 145 53 163 68 
H-negative risk:  675 678 1134 1107 404 393 100 80 163 145 68 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 75 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
187 
disease_progression 
H-positive risk:  680 675 79 1116 389 99 1129 401 148 54 162 68 
H-negative risk:  675 680 1129 1116 401 389 99 79 162 148 68 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
188 
disease_progression 
H-positive risk:  682 677 82 1114 383 97 1134 403 149 53 160 66 
H-negative risk:  677 682 1134 1114 403 383 97 82 160 149 66 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
189 
disease_progression 
H-positive risk:  684 674 84 1109 380 95 1134 401 157 53 161 68 
H-negative risk:  674 684 1134 1109 401 380 95 84 161 157 68 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
190 
disease_progression 
H-positive risk:  687 678 84 1113 380 96 1136 393 157 53 160 63 
H-negative risk:  678 687 1136 1113 393 380 96 84 160 157 63 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
191 
disease_progression 
H-positive risk:  678 672 84 1119 384 101 1141 388 152 55 162 64 
H-negative risk:  672 678 1141 1119 388 384 101 84 162 152 64 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
192 
disease_progression 
H-positive risk:  686 673 85 1124 381 98 1129 397 150 54 161 62 
H-negative risk:  673 686 1129 1124 397 381 98 85 161 150 62 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
193 
disease_progression 
H-positive risk:  688 668 89 1128 378 102 1119 397 154 52 162 63 
H-negative risk:  668 688 1119 1128 397 378 102 89 162 154 63 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
95 new agents 
194 
disease_progression 
H-positive risk:  693 662 88 1118 390 104 1111 409 152 51 158 64 
H-negative risk:  662 693 1111 1118 409 390 104 88 158 152 64 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 83 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
195 
disease_progression 
H-positive risk:  694 666 88 1113 393 104 1104 418 150 50 155 65 
H-negative risk:  666 694 1104 1113 418 393 104 88 155 150 65 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
196 
disease_progression 
H-positive risk:  689 673 89 1084 407 102 1111 419 153 54 154 65 
H-negative risk:  673 689 1111 1084 419 407 102 89 154 153 65 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
197 
disease_progression 
H-positive risk:  693 673 91 1079 413 103 1101 424 151 58 153 61 
H-negative risk:  673 693 1101 1079 424 413 103 91 153 151 61 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
198 
disease_progression 
H-positive risk:  690 672 95 1079 415 101 1102 423 153 58 152 60 
H-negative risk:  672 690 1102 1079 423 415 101 95 152 153 60 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 85 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
199 
disease_progression 
H-positive risk:  690 680 94 1079 409 98 1107 420 156 56 149 62 
H-negative risk:  680 690 1107 1079 420 409 98 94 149 156 62 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 85 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
200 
disease_progression 
H-positive risk:  691 690 94 1078 409 99 1108 416 155 53 148 59 
H-negative risk:  690 691 1108 1078 416 409 99 94 148 155 59 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 87 14 

clinical_engagement 
diagnosis 
demography 
72 new agents 
201 
disease_progression 
H-positive risk:  687 687 90 1079 406 101 1117 416 154 51 153 59 
H-negative risk:  687 687 1117 1079 416 406 101 90 153 154 59 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 85 12 

clinical_engagement 
diagnosis 
demography 
76 new agents 
202 
disease_progression 
H-positive risk:  690 698 88 1075 407 98 1113 415 155 52 148 61 
H-negative risk:  698 690 1113 1075 415 407 98 88 148 155 61 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 85 12 

clinical_engagement 
diagnosis 
demography 
80 new agents 
203 
disease_progression 
H-positive risk:  688 695 88 1092 402 96 1119 405 154 52 148 61 
H-negative risk:  695 688 1119 1092 405 402 96 88 148 154 61 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 83 14 

clinical_engagement 
diagnosis 
demography 
70 new agents 
204 
disease_progression 
H-positive risk:  685 692 91 1086 406 99 1125 401 151 53 152 59 
H-negative risk:  692 685 1125 1086 401 406 99 91 152 151 59 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 79 14 

clinical_engagement 
diagnosis 
demography 
74 new agents 
205 
disease_progression 
H-positive risk:  682 692 93 1081 412 97 1127 398 153 53 150 62 
H-negative risk:  692 682 1127 1081 398 412 97 93 150 153 62 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
94 new agents 
206 
disease_progression 
H-positive risk:  687 698 93 1077 424 95 1117 386 153 57 147 66 
H-negative risk:  698 687 1117 1077 386 424 95 93 147 153 66 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
92 new agents 
207 
disease_progression 
H-positive risk:  690 701 91 1068 427 98 1118 384 154 56 147 66 
H-negative risk:  701 690 1118 1068 384 427 98 91 147 154 66 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 77 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
208 
disease_progression 
H-positive risk:  693 694 91 1069 426 97 1123 385 156 56 145 65 
H-negative risk:  694 693 1123 1069 385 426 97 91 145 156 65 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
209 
disease_progression 
H-positive risk:  692 691 93 1068 422 95 1120 392 158 57 147 65 
H-negative risk:  691 692 1120 1068 392 422 95 93 147 158 65 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 81 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
210 
disease_progression 
H-positive risk:  685 682 95 1075 418 96 1128 391 157 58 152 63 
H-negative risk:  682 685 1128 1075 391 418 96 95 152 157 63 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 82 14 

clinical_engagement 
diagnosis 
demography 
87 new agents 
211 
disease_progression 
H-positive risk:  681 678 97 1082 407 99 1131 394 158 58 151 64 
H-negative risk:  678 681 1131 1082 394 407 99 97 151 158 64 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
94 new agents 
212 
disease_progression 
H-positive risk:  692 678 97 1074 409 101 1141 383 157 58 145 65 
H-negative risk:  678 692 1141 1074 383 409 101 97 145 157 65 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
213 
disease_progression 
H-positive risk:  690 678 95 1075 410 103 1141 383 158 57 145 65 
H-negative risk:  678 690 1141 1075 383 410 103 95 145 158 65 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
214 
disease_progression 
H-positive risk:  692 675 93 1079 408 101 1151 377 161 58 143 62 
H-negative risk:  675 692 1151 1079 377 408 101 93 143 161 62 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
215 
disease_progression 
H-positive risk:  692 674 92 1081 413 100 1152 376 161 57 142 60 
H-negative risk:  674 692 1152 1081 376 413 100 92 142 161 60 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
55 new agents 
216 
disease_progression 
H-positive risk:  688 669 91 1081 423 99 1148 376 163 56 146 60 
H-negative risk:  669 688 1148 1081 376 423 99 91 146 163 60 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
85 new agents 
217 
disease_progression 
H-positive risk:  690 667 91 1065 440 99 1134 388 159 58 148 61 
H-negative risk:  667 690 1134 1065 388 440 99 91 148 159 61 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 85 14 

clinical_engagement 
diagnosis 
demography 
77 new agents 
218 
disease_progression 
H-positive risk:  691 668 89 1071 431 96 1144 382 160 57 150 61 
H-negative risk:  668 691 1144 1071 382 431 96 89 150 160 61 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 87 14 

clinical_engagement 
diagnosis 
demography 
78 new agents 
219 
disease_progression 
H-positive risk:  698 659 91 1080 431 96 1139 381 158 57 149 61 
H-negative risk:  659 698 1139 1080 381 431 96 91 149 158 61 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 89 14 

clinical_engagement 
diagnosis 
demography 
78 new agents 
220 
disease_progression 
H-positive risk:  708 662 91 1077 422 97 1132 386 158 56 148 63 
H-negative risk:  662 708 1132 1077 386 422 97 91 148 158 63 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 92 13 

clinical_engagement 
diagnosis 
demography 
85 new agents 
221 
disease_progression 
H-positive risk:  710 658 90 1071 433 98 1131 393 155 53 149 59 
H-negative risk:  658 710 1131 1071 393 433 98 90 149 155 59 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 95 13 

clinical_engagement 
diagnosis 
demography 
74 new agents 
222 
disease_progression 
H-positive risk:  708 657 88 1067 440 98 1125 397 155 55 149 61 
H-negative risk:  657 708 1125 1067 397 440 98 88 149 155 61 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 97 13 

clinical_engagement 
diagnosis 
demography 
80 new agents 
223 
disease_progression 
H-positive risk:  708 652 83 1059 444 99 1132 406 150 55 150 62 
H-negative risk:  652 708 1132 1059 406 444 99 83 150 150 62 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 97 13 

clinical_engagement 
diagnosis 
demography 
74 new agents 
224 
disease_progression 
H-positive risk:  704 652 86 1065 443 99 1139 403 146 54 149 60 
H-negative risk:  652 704 1139 1065 403 443 99 86 149 146 60 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 99 12 

clinical_engagement 
diagnosis 
demography 
68 new agents 
225 
disease_progression 
H-positive risk:  706 653 85 1069 441 100 1140 400 145 52 150 59 
H-negative risk:  653 706 1140 1069 400 441 100 85 150 145 59 52 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 100 12 

clinical_engagement 
diagnosis 
demography 
75 new agents 
226 
disease_progression 
H-positive risk:  699 654 86 1064 442 103 1143 407 144 54 148 56 
H-negative risk:  654 699 1143 1064 407 442 103 86 148 144 56 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 101 13 

clinical_engagement 
diagnosis 
demography 
85 new agents 
227 
disease_progression 
H-positive risk:  706 660 84 1057 440 101 1137 406 146 56 150 57 
H-negative risk:  660 706 1137 1057 406 440 101 84 150 146 57 56 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 105 13 

clinical_engagement 
diagnosis 
demography 
74 new agents 
228 
disease_progression 
H-positive risk:  713 662 84 1050 439 104 1138 403 144 57 151 55 
H-negative risk:  662 713 1138 1050 403 439 104 84 151 144 55 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 100 13 

clinical_engagement 
diagnosis 
demography 
72 new agents 
229 
disease_progression 
H-positive risk:  712 668 84 1048 442 103 1132 402 145 57 151 56 
H-negative risk:  668 712 1132 1048 402 442 103 84 151 145 56 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 101 13 

clinical_engagement 
diagnosis 
demography 
72 new agents 
230 
disease_progression 
H-positive risk:  710 671 84 1047 445 107 1128 399 143 58 151 57 
H-negative risk:  671 710 1128 1047 399 445 107 84 151 143 57 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 101 12 

clinical_engagement 
diagnosis 
demography 
80 new agents 
231 
disease_progression 
H-positive risk:  716 675 85 1040 446 108 1126 406 141 56 142 59 
H-negative risk:  675 716 1126 1040 406 446 108 85 142 141 59 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 103 12 

clinical_engagement 
diagnosis 
demography 
79 new agents 
232 
disease_progression 
H-positive risk:  715 673 85 1037 446 111 1124 409 139 60 143 58 
H-negative risk:  673 715 1124 1037 409 446 111 85 143 139 58 60 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 104 13 

clinical_engagement 
diagnosis 
demography 
79 new agents 
233 
disease_progression 
H-positive risk:  718 677 87 1030 448 110 1115 416 137 61 144 57 
H-negative risk:  677 718 1115 1030 416 448 110 87 144 137 57 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 101 11 

clinical_engagement 
diagnosis 
demography 
65 new agents 
234 
disease_progression 
H-positive risk:  718 681 87 1024 450 108 1115 418 141 60 141 57 
H-negative risk:  681 718 1115 1024 418 450 108 87 141 141 57 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 101 11 

clinical_engagement 
diagnosis 
demography 
76 new agents 
235 
disease_progression 
H-positive risk:  718 677 89 1021 456 106 1108 427 140 63 137 58 
H-negative risk:  677 718 1108 1021 427 456 106 89 137 140 58 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 103 10 

clinical_engagement 
diagnosis 
demography 
77 new agents 
236 
disease_progression 
H-positive risk:  721 668 88 1024 452 106 1111 427 143 63 141 56 
H-negative risk:  668 721 1111 1024 427 452 106 88 141 143 56 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 100 8 

clinical_engagement 
diagnosis 
demography 
66 new agents 
237 
disease_progression 
H-positive risk:  720 673 88 1022 448 107 1103 435 143 65 142 54 
H-negative risk:  673 720 1103 1022 435 448 107 88 142 143 54 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 101 9 

clinical_engagement 
diagnosis 
demography 
60 new agents 
238 
disease_progression 
H-positive risk:  713 673 89 1024 448 107 1105 431 144 64 147 55 
H-negative risk:  673 713 1105 1024 431 448 107 89 147 144 55 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 100 9 

clinical_engagement 
diagnosis 
demography 
84 new agents 
239 
disease_progression 
H-positive risk:  721 677 90 1021 441 110 1099 437 146 57 146 55 
H-negative risk:  677 721 1099 1021 437 441 110 90 146 146 55 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 99 10 

clinical_engagement 
diagnosis 
demography 
82 new agents 
240 
disease_progression 
H-positive risk:  720 677 91 1019 440 110 1100 439 146 53 149 56 
H-negative risk:  677 720 1100 1019 439 440 110 91 149 146 56 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 99 10 

clinical_engagement 
diagnosis 
demography 
76 new agents 
241 
disease_progression 
H-positive risk:  715 685 90 1001 448 110 1092 447 148 53 151 60 
H-negative risk:  685 715 1092 1001 447 448 110 90 151 148 60 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 100 11 

clinical_engagement 
diagnosis 
demography 
70 new agents 
242 
disease_progression 
H-positive risk:  703 690 88 1005 452 105 1092 443 153 57 152 60 
H-negative risk:  690 703 1092 1005 443 452 105 88 152 153 60 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 104 9 

clinical_engagement 
diagnosis 
demography 
79 new agents 
243 
disease_progression 
H-positive risk:  705 680 88 1012 453 105 1091 444 151 57 151 63 
H-negative risk:  680 705 1091 1012 444 453 105 88 151 151 63 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 105 11 

clinical_engagement 
diagnosis 
demography 
61 new agents 
244 
disease_progression 
H-positive risk:  702 678 92 1008 455 102 1093 448 153 54 149 66 
H-negative risk:  678 702 1093 1008 448 455 102 92 149 153 66 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 105 11 

clinical_engagement 
diagnosis 
demography 
79 new agents 
245 
disease_progression 
H-positive risk:  703 677 93 1015 450 103 1092 450 153 50 151 63 
H-negative risk:  677 703 1092 1015 450 450 103 93 151 153 63 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 102 9 

clinical_engagement 
diagnosis 
demography 
83 new agents 
246 
disease_progression 
H-positive risk:  702 680 91 1022 442 105 1088 456 153 49 149 63 
H-negative risk:  680 702 1088 1022 456 442 105 91 149 153 63 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 102 10 

clinical_engagement 
diagnosis 
demography 
75 new agents 
247 
disease_progression 
H-positive risk:  706 679 90 1027 445 105 1086 451 154 48 150 59 
H-negative risk:  679 706 1086 1027 451 445 105 90 150 154 59 48 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 102 10 

clinical_engagement 
diagnosis 
demography 
73 new agents 
248 
disease_progression 
H-positive risk:  713 677 89 1019 440 103 1098 454 151 48 146 62 
H-negative risk:  677 713 1098 1019 454 440 103 89 146 151 62 48 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 100 11 

clinical_engagement 
diagnosis 
demography 
88 new agents 
249 
disease_progression 
H-positive risk:  709 678 90 1026 429 102 1103 452 154 47 147 63 
H-negative risk:  678 709 1103 1026 452 429 102 90 147 154 63 47 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 99 10 

clinical_engagement 
diagnosis 
demography 
81 new agents 
250 
disease_progression 
H-positive risk:  710 665 90 1042 426 105 1099 453 153 46 150 61 
H-negative risk:  665 710 1099 1042 453 426 105 90 150 153 61 46 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 101 10 

clinical_engagement 
diagnosis 
demography 
74 new agents 
251 
disease_progression 
H-positive risk:  705 672 89 1032 421 106 1105 457 153 47 148 65 
H-negative risk:  672 705 1105 1032 457 421 106 89 148 153 65 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 103 10 

clinical_engagement 
diagnosis 
demography 
63 new agents 
252 
disease_progression 
H-positive risk:  703 667 90 1024 431 110 1110 448 155 49 148 65 
H-negative risk:  667 703 1110 1024 448 431 110 90 148 155 65 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 106 10 

clinical_engagement 
diagnosis 
demography 
67 new agents 
253 
disease_progression 
H-positive risk:  697 666 91 1030 437 107 1104 449 154 48 149 68 
H-negative risk:  666 697 1104 1030 449 437 107 91 149 154 68 48 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 103 10 

clinical_engagement 
diagnosis 
demography 
110 new agents 
254 
disease_progression 
H-positive risk:  712 662 89 1039 428 111 1100 440 152 50 152 65 
H-negative risk:  662 712 1100 1039 440 428 111 89 152 152 65 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 102 10 

clinical_engagement 
diagnosis 
demography 
71 new agents 
255 
disease_progression 
H-positive risk:  712 658 90 1038 432 112 1101 437 152 53 151 64 
H-negative risk:  658 712 1101 1038 437 432 112 90 151 152 64 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 101 10 

clinical_engagement 
diagnosis 
demography 
69 new agents 
256 
disease_progression 
H-positive risk:  702 659 90 1044 439 113 1100 435 151 51 151 65 
H-negative risk:  659 702 1100 1044 435 439 113 90 151 151 65 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 100 10 

clinical_engagement 
diagnosis 
demography 
79 new agents 
257 
disease_progression 
H-positive risk:  707 657 92 1049 437 112 1099 429 155 50 148 65 
H-negative risk:  657 707 1099 1049 429 437 112 92 148 155 65 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 98 10 

clinical_engagement 
diagnosis 
demography 
64 new agents 
258 
disease_progression 
H-positive risk:  704 658 93 1039 444 111 1106 426 154 54 149 62 
H-negative risk:  658 704 1106 1039 426 444 111 93 149 154 62 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 96 8 

clinical_engagement 
diagnosis 
demography 
68 new agents 
259 
disease_progression 
H-positive risk:  702 653 92 1032 445 111 1113 429 151 56 152 64 
H-negative risk:  653 702 1113 1032 429 445 111 92 152 151 64 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 95 8 

clinical_engagement 
diagnosis 
demography 
73 new agents 
260 
disease_progression 
H-positive risk:  702 651 90 1032 442 112 1114 432 149 59 153 64 
H-negative risk:  651 702 1114 1032 432 442 112 90 153 149 64 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 98 8 

clinical_engagement 
diagnosis 
demography 
98 new agents 
261 
disease_progression 
H-positive risk:  697 657 91 1039 434 113 1109 435 150 57 153 65 
H-negative risk:  657 697 1109 1039 435 434 113 91 153 150 65 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 97 9 

clinical_engagement 
diagnosis 
demography 
84 new agents 
262 
disease_progression 
H-positive risk:  700 657 95 1031 438 113 1107 437 152 56 152 62 
H-negative risk:  657 700 1107 1031 437 438 113 95 152 152 62 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 90 8 

clinical_engagement 
diagnosis 
demography 
59 new agents 
263 
disease_progression 
H-positive risk:  684 661 94 1037 440 110 1121 432 153 57 149 62 
H-negative risk:  661 684 1121 1037 432 440 110 94 149 153 62 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 85 8 

clinical_engagement 
diagnosis 
demography 
68 new agents 
264 
disease_progression 
H-positive risk:  676 659 92 1042 435 114 1130 437 154 55 144 62 
H-negative risk:  659 676 1130 1042 437 435 114 92 144 154 62 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 86 8 

clinical_engagement 
diagnosis 
demography 
64 new agents 
265 
disease_progression 
H-positive risk:  672 660 93 1051 440 113 1133 426 152 53 143 64 
H-negative risk:  660 672 1133 1051 426 440 113 93 143 152 64 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 87 8 

clinical_engagement 
diagnosis 
demography 
84 new agents 
266 
disease_progression 
H-positive risk:  673 661 96 1056 430 110 1134 425 153 54 144 64 
H-negative risk:  661 673 1134 1056 425 430 110 96 144 153 64 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 83 9 

clinical_engagement 
diagnosis 
demography 
87 new agents 
267 
disease_progression 
H-positive risk:  680 656 96 1060 429 109 1125 427 154 54 143 67 
H-negative risk:  656 680 1125 1060 427 429 109 96 143 154 67 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 81 9 

clinical_engagement 
diagnosis 
demography 
90 new agents 
268 
disease_progression 
H-positive risk:  681 650 95 1066 428 112 1113 434 157 53 144 67 
H-negative risk:  650 681 1113 1066 434 428 112 95 144 157 67 53 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 83 9 

clinical_engagement 
diagnosis 
demography 
72 new agents 
269 
disease_progression 
H-positive risk:  680 654 95 1066 429 112 1097 441 158 54 147 67 
H-negative risk:  654 680 1097 1066 441 429 112 95 147 158 67 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 83 9 

clinical_engagement 
diagnosis 
demography 
69 new agents 
270 
disease_progression 
H-positive risk:  681 658 96 1058 437 110 1090 439 158 55 145 73 
H-negative risk:  658 681 1090 1058 439 437 110 96 145 158 73 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 85 10 

clinical_engagement 
diagnosis 
demography 
89 new agents 
271 
disease_progression 
H-positive risk:  681 665 99 1050 440 110 1087 438 156 57 144 73 
H-negative risk:  665 681 1087 1050 438 440 110 99 144 156 73 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 87 10 

clinical_engagement 
diagnosis 
demography 
71 new agents 
272 
disease_progression 
H-positive risk:  682 664 100 1051 435 112 1090 438 157 57 142 72 
H-negative risk:  664 682 1090 1051 438 435 112 100 142 157 72 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 89 9 

clinical_engagement 
diagnosis 
demography 
81 new agents 
273 
disease_progression 
H-positive risk:  685 655 97 1053 438 111 1088 442 157 59 145 70 
H-negative risk:  655 685 1088 1053 442 438 111 97 145 157 70 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 90 11 

clinical_engagement 
diagnosis 
demography 
74 new agents 
274 
disease_progression 
H-positive risk:  679 655 97 1063 433 112 1085 446 157 60 144 69 
H-negative risk:  655 679 1085 1063 446 433 112 97 144 157 69 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 92 13 

clinical_engagement 
diagnosis 
demography 
73 new agents 
275 
disease_progression 
H-positive risk:  683 657 98 1067 429 117 1076 444 158 59 145 67 
H-negative risk:  657 683 1076 1067 444 429 117 98 145 158 67 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 93 13 

clinical_engagement 
diagnosis 
demography 
77 new agents 
276 
disease_progression 
H-positive risk:  686 653 98 1065 427 118 1086 440 157 60 145 65 
H-negative risk:  653 686 1086 1065 440 427 118 98 145 157 65 60 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 100 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
277 
disease_progression 
H-positive risk:  683 657 97 1063 425 120 1090 443 154 60 142 66 
H-negative risk:  657 683 1090 1063 443 425 120 97 142 154 66 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 96 15 

clinical_engagement 
diagnosis 
demography 
83 new agents 
278 
disease_progression 
H-positive risk:  682 661 94 1057 426 120 1095 439 155 59 145 67 
H-negative risk:  661 682 1095 1057 439 426 120 94 145 155 67 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 95 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
279 
disease_progression 
H-positive risk:  682 673 95 1061 421 118 1091 431 154 62 144 68 
H-negative risk:  673 682 1091 1061 431 421 118 95 144 154 68 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 92 16 

clinical_engagement 
diagnosis 
demography 
82 new agents 
280 
disease_progression 
H-positive risk:  681 680 97 1055 422 120 1091 425 156 62 143 68 
H-negative risk:  680 681 1091 1055 425 422 120 97 143 156 68 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 90 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
281 
disease_progression 
H-positive risk:  674 685 94 1053 429 119 1092 420 155 64 148 67 
H-negative risk:  685 674 1092 1053 420 429 119 94 148 155 67 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
93 new agents 
282 
disease_progression 
H-positive risk:  683 689 93 1048 440 119 1096 407 150 62 145 68 
H-negative risk:  689 683 1096 1048 407 440 119 93 145 150 68 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 93 15 

clinical_engagement 
diagnosis 
demography 
85 new agents 
283 
disease_progression 
H-positive risk:  685 692 94 1056 435 118 1097 399 153 59 144 68 
H-negative risk:  692 685 1097 1056 399 435 118 94 144 153 68 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
284 
disease_progression 
H-positive risk:  678 692 93 1064 428 116 1108 398 155 59 140 69 
H-negative risk:  692 678 1108 1064 398 428 116 93 140 155 69 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
79 new agents 
285 
disease_progression 
H-positive risk:  674 689 94 1066 423 111 1125 397 157 60 135 69 
H-negative risk:  689 674 1125 1066 397 423 111 94 135 157 69 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 90 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
286 
disease_progression 
H-positive risk:  677 687 93 1067 421 114 1121 393 158 59 138 72 
H-negative risk:  687 677 1121 1067 393 421 114 93 138 158 72 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 85 14 

clinical_engagement 
diagnosis 
demography 
83 new agents 
287 
disease_progression 
H-positive risk:  678 686 93 1065 417 118 1114 399 159 58 143 70 
H-negative risk:  686 678 1114 1065 399 417 118 93 143 159 70 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 83 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
288 
disease_progression 
H-positive risk:  676 681 92 1077 414 115 1107 403 165 58 143 69 
H-negative risk:  681 676 1107 1077 403 414 115 92 143 165 69 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 85 15 

clinical_engagement 
diagnosis 
demography 
79 new agents 
289 
disease_progression 
H-positive risk:  672 684 93 1083 403 113 1110 405 165 57 147 68 
H-negative risk:  684 672 1110 1083 405 403 113 93 147 165 68 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 79 15 

clinical_engagement 
diagnosis 
demography 
96 new agents 
290 
disease_progression 
H-positive risk:  690 676 96 1091 392 111 1106 407 164 55 147 65 
H-negative risk:  676 690 1106 1091 407 392 111 96 147 164 65 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
291 
disease_progression 
H-positive risk:  688 674 94 1087 397 112 1113 405 161 57 146 66 
H-negative risk:  674 688 1113 1087 405 397 112 94 146 161 66 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 75 16 

clinical_engagement 
diagnosis 
demography 
88 new agents 
292 
disease_progression 
H-positive risk:  684 681 97 1089 398 108 1109 403 164 57 143 67 
H-negative risk:  681 684 1109 1089 403 398 108 97 143 164 67 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
293 
disease_progression 
H-positive risk:  685 687 97 1075 406 110 1108 407 163 54 143 65 
H-negative risk:  687 685 1108 1075 407 406 110 97 143 163 65 54 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
294 
disease_progression 
H-positive risk:  687 692 96 1072 415 107 1110 399 162 54 143 63 
H-negative risk:  692 687 1110 1072 399 415 107 96 143 162 63 54 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
295 
disease_progression 
H-positive risk:  688 684 99 1075 412 108 1110 402 164 53 139 66 
H-negative risk:  684 688 1110 1075 402 412 108 99 139 164 66 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
296 
disease_progression 
H-positive risk:  685 683 99 1066 420 109 1106 413 166 53 136 64 
H-negative risk:  683 685 1106 1066 413 420 109 99 136 166 64 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
297 
disease_progression 
H-positive risk:  681 676 101 1061 422 106 1114 415 171 53 138 62 
H-negative risk:  676 681 1114 1061 415 422 106 101 138 171 62 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
298 
disease_progression 
H-positive risk:  686 672 102 1065 422 109 1111 413 168 54 138 60 
H-negative risk:  672 686 1111 1065 413 422 109 102 138 168 60 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
299 
disease_progression 
H-positive risk:  684 675 101 1070 421 108 1102 416 173 53 135 62 
H-negative risk:  675 684 1102 1070 416 421 108 101 135 173 62 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
300 
disease_progression 
H-positive risk:  680 682 98 1066 422 107 1107 412 174 55 136 61 
H-negative risk:  682 680 1107 1066 412 422 107 98 136 174 61 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
301 
disease_progression 
H-positive risk:  679 672 97 1066 423 110 1107 414 174 58 138 62 
H-negative risk:  672 679 1107 1066 414 423 110 97 138 174 62 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
302 
disease_progression 
H-positive risk:  682 676 97 1061 421 109 1112 410 177 58 136 61 
H-negative risk:  676 682 1112 1061 410 421 109 97 136 177 61 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
94 new agents 
303 
disease_progression 
H-positive risk:  684 680 98 1060 417 109 1113 411 175 58 136 59 
H-negative risk:  680 684 1113 1060 411 417 109 98 136 175 59 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
304 
disease_progression 
H-positive risk:  684 673 100 1062 422 109 1118 405 170 59 137 61 
H-negative risk:  673 684 1118 1062 405 422 109 100 137 170 61 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
55 new agents 
305 
disease_progression 
H-positive risk:  682 670 98 1065 436 110 1113 399 166 62 141 58 
H-negative risk:  670 682 1113 1065 399 436 110 98 141 166 58 62 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
306 
disease_progression 
H-positive risk:  673 672 100 1070 432 114 1122 397 164 59 136 61 
H-negative risk:  672 673 1122 1070 397 432 114 100 136 164 61 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
307 
disease_progression 
H-positive risk:  668 676 99 1063 441 113 1133 389 162 56 140 60 
H-negative risk:  676 668 1133 1063 389 441 113 99 140 162 60 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
308 
disease_progression 
H-positive risk:  672 674 97 1060 441 113 1135 387 164 58 142 57 
H-negative risk:  674 672 1135 1060 387 441 113 97 142 164 57 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
309 
disease_progression 
H-positive risk:  673 682 96 1060 427 115 1134 388 165 60 145 55 
H-negative risk:  682 673 1134 1060 388 427 115 96 145 165 55 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
310 
disease_progression 
H-positive risk:  666 680 97 1070 415 114 1145 381 163 64 149 56 
H-negative risk:  680 666 1145 1070 381 415 114 97 149 163 56 64 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
311 
disease_progression 
H-positive risk:  675 679 100 1062 415 114 1143 381 164 64 149 54 
H-negative risk:  679 675 1143 1062 381 415 114 100 149 164 54 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
61 new agents 
312 
disease_progression 
H-positive risk:  678 671 100 1051 419 115 1143 391 163 66 149 54 
H-negative risk:  671 678 1143 1051 391 419 115 100 149 163 54 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 70 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
313 
disease_progression 
H-positive risk:  676 675 100 1036 423 119 1141 394 163 70 150 53 
H-negative risk:  675 676 1141 1036 394 423 119 100 150 163 53 70 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 70 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
314 
disease_progression 
H-positive risk:  668 669 98 1039 418 121 1147 400 164 69 152 55 
H-negative risk:  669 668 1147 1039 400 418 121 98 152 164 55 69 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 70 32 

clinical_engagement 
diagnosis 
demography 
86 new agents 
315 
disease_progression 
H-positive risk:  669 672 97 1040 419 121 1148 397 167 65 151 54 
H-negative risk:  672 669 1148 1040 397 419 121 97 151 167 54 65 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
86 new agents 
316 
disease_progression 
H-positive risk:  674 665 99 1046 420 119 1139 404 165 62 154 53 
H-negative risk:  665 674 1139 1046 404 420 119 99 154 165 53 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 71 34 

clinical_engagement 
diagnosis 
demography 
56 new agents 
317 
disease_progression 
H-positive risk:  675 662 101 1047 419 120 1131 410 165 63 151 56 
H-negative risk:  662 675 1131 1047 410 419 120 101 151 165 56 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 69 37 

clinical_engagement 
diagnosis 
demography 
85 new agents 
318 
disease_progression 
H-positive risk:  673 666 102 1051 415 120 1131 407 166 61 152 56 
H-negative risk:  666 673 1131 1051 407 415 120 102 152 166 56 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 70 36 

clinical_engagement 
diagnosis 
demography 
67 new agents 
319 
disease_progression 
H-positive risk:  673 662 102 1054 422 118 1125 412 163 63 151 55 
H-negative risk:  662 673 1125 1054 412 422 118 102 151 163 55 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 75 37 

clinical_engagement 
diagnosis 
demography 
81 new agents 
320 
disease_progression 
H-positive risk:  671 663 103 1060 420 116 1119 414 162 64 151 57 
H-negative risk:  663 671 1119 1060 414 420 116 103 151 162 57 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 75 37 

clinical_engagement 
diagnosis 
demography 
86 new agents 
321 
disease_progression 
H-positive risk:  674 663 102 1063 421 113 1121 413 162 63 148 57 
H-negative risk:  663 674 1121 1063 413 421 113 102 148 162 57 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 72 37 

clinical_engagement 
diagnosis 
demography 
82 new agents 
322 
disease_progression 
H-positive risk:  678 672 102 1066 417 113 1105 418 163 63 143 60 
H-negative risk:  672 678 1105 1066 418 417 113 102 143 163 60 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 77 37 

clinical_engagement 
diagnosis 
demography 
66 new agents 
323 
disease_progression 
H-positive risk:  684 673 101 1071 418 113 1093 414 166 63 143 61 
H-negative risk:  673 684 1093 1071 414 418 113 101 143 166 61 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 77 37 

clinical_engagement 
diagnosis 
demography 
82 new agents 
324 
disease_progression 
H-positive risk:  681 672 101 1070 418 112 1106 405 171 62 143 59 
H-negative risk:  672 681 1106 1070 405 418 112 101 143 171 59 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 75 37 

clinical_engagement 
diagnosis 
demography 
80 new agents 
325 
disease_progression 
H-positive risk:  680 669 100 1071 414 116 1097 416 172 62 142 61 
H-negative risk:  669 680 1097 1071 416 414 116 100 142 172 61 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 72 37 

clinical_engagement 
diagnosis 
demography 
80 new agents 
326 
disease_progression 
H-positive risk:  683 675 98 1074 414 119 1089 410 171 64 144 59 
H-negative risk:  675 683 1089 1074 410 414 119 98 144 171 59 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 73 39 

clinical_engagement 
diagnosis 
demography 
95 new agents 
327 
disease_progression 
H-positive risk:  674 676 98 1076 416 118 1088 418 172 61 141 62 
H-negative risk:  676 674 1088 1076 418 416 118 98 141 172 62 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 68 38 

clinical_engagement 
diagnosis 
demography 
84 new agents 
328 
disease_progression 
H-positive risk:  680 679 96 1075 411 119 1088 411 172 62 142 65 
H-negative risk:  679 680 1088 1075 411 411 119 96 142 172 65 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 67 37 

clinical_engagement 
diagnosis 
demography 
85 new agents 
329 
disease_progression 
H-positive risk:  676 685 93 1073 415 118 1087 411 172 62 144 64 
H-negative risk:  685 676 1087 1073 411 415 118 93 144 172 64 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 68 37 

clinical_engagement 
diagnosis 
demography 
76 new agents 
330 
disease_progression 
H-positive risk:  684 689 90 1065 413 118 1081 411 177 60 147 65 
H-negative risk:  689 684 1081 1065 411 413 118 90 147 177 65 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 68 36 

clinical_engagement 
diagnosis 
demography 
83 new agents 
331 
disease_progression 
H-positive risk:  694 693 91 1061 409 116 1084 408 173 61 145 65 
H-negative risk:  693 694 1084 1061 408 409 116 91 145 173 65 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 69 36 

clinical_engagement 
diagnosis 
demography 
64 new agents 
332 
disease_progression 
H-positive risk:  696 698 87 1054 405 118 1076 416 174 62 149 65 
H-negative risk:  698 696 1076 1054 416 405 118 87 149 174 65 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 66 35 

clinical_engagement 
diagnosis 
demography 
76 new agents 
333 
disease_progression 
H-positive risk:  699 703 88 1052 408 117 1071 409 178 62 147 66 
H-negative risk:  703 699 1071 1052 409 408 117 88 147 178 66 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 68 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
334 
disease_progression 
H-positive risk:  703 700 84 1057 405 115 1068 415 175 63 146 69 
H-negative risk:  700 703 1068 1057 415 405 115 84 146 175 69 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 66 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
335 
disease_progression 
H-positive risk:  702 693 87 1059 405 115 1069 422 168 64 149 67 
H-negative risk:  693 702 1069 1059 422 405 115 87 149 168 67 64 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 65 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
336 
disease_progression 
H-positive risk:  704 695 86 1052 410 111 1068 423 175 61 150 65 
H-negative risk:  695 704 1068 1052 423 410 111 86 150 175 65 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 66 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
337 
disease_progression 
H-positive risk:  708 692 88 1064 410 109 1067 419 174 60 147 62 
H-negative risk:  692 708 1067 1064 419 410 109 88 147 174 62 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 65 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
338 
disease_progression 
H-positive risk:  704 689 89 1068 407 108 1078 417 172 61 146 61 
H-negative risk:  689 704 1078 1068 417 407 108 89 146 172 61 61 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 63 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
339 
disease_progression 
H-positive risk:  710 694 86 1061 400 112 1076 417 169 63 152 60 
H-negative risk:  694 710 1076 1061 417 400 112 86 152 169 60 63 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 65 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
340 
disease_progression 
H-positive risk:  712 698 84 1062 397 113 1069 421 170 61 152 61 
H-negative risk:  698 712 1069 1062 421 397 113 84 152 170 61 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 65 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
341 
disease_progression 
H-positive risk:  703 695 88 1064 404 112 1071 422 168 59 153 61 
H-negative risk:  695 703 1071 1064 422 404 112 88 153 168 61 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
342 
disease_progression 
H-positive risk:  706 688 87 1074 404 111 1065 423 168 63 153 58 
H-negative risk:  688 706 1065 1074 423 404 111 87 153 168 58 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
343 
disease_progression 
H-positive risk:  709 690 88 1071 398 112 1064 425 166 65 153 59 
H-negative risk:  690 709 1064 1071 425 398 112 88 153 166 59 65 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 66 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
344 
disease_progression 
H-positive risk:  704 698 87 1073 396 111 1060 424 169 69 152 57 
H-negative risk:  698 704 1060 1073 424 396 111 87 152 169 57 69 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
345 
disease_progression 
H-positive risk:  710 695 84 1069 395 112 1054 430 172 70 152 57 
H-negative risk:  695 710 1054 1069 430 395 112 84 152 172 57 70 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 64 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
346 
disease_progression 
H-positive risk:  709 703 82 1074 394 111 1053 424 169 69 155 57 
H-negative risk:  703 709 1053 1074 424 394 111 82 155 169 57 69 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
347 
disease_progression 
H-positive risk:  702 704 84 1088 391 107 1050 424 171 67 155 57 
H-negative risk:  704 702 1050 1088 424 391 107 84 155 171 57 67 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 66 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
348 
disease_progression 
H-positive risk:  701 701 84 1090 390 108 1046 431 168 68 155 58 
H-negative risk:  701 701 1046 1090 431 390 108 84 155 168 58 68 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
60 new agents 
349 
disease_progression 
H-positive risk:  700 698 83 1097 385 108 1049 428 170 66 157 59 
H-negative risk:  698 700 1049 1097 428 385 108 83 157 170 59 66 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
slurmstepd-midway2-0318: error: *** JOB 2263470 ON midway2-0318 CANCELLED AT 2020-06-08T19:02:34 DUE TO TIME LIMIT ***
